Directory
>
Kevin Lumb
Kevin Lumb
Vice President, Discovery Sciences | Monte Rosa Therapeutics
Upper Providence Township, Pennsylvania, United States
Kevin Lumb
Summary
Kevin Lumb is a seasoned leader in drug discovery, specializing in pharmacology and structural biology. With a proven track record of building high-performing teams, he has effectively managed both internal and external resources to drive innovative drug development. His expertise spans from target validation to preclinical candidate discovery, showcasing his ability to navigate complex processes and clarify executable strategies. Kevin has authored 54 publications and holds 9 patents, reflecting his deep commitment to advancing scientific knowledge. His leadership style emphasizes talent development and creating self-managing teams, fostering an environment of collaboration and innovation. He has successfully led teams in various prestigious organizations, including Merck and Janssen, demonstrating his adaptability across different corporate cultures. Kevin's strategic vision in capital planning and execution has also garnered him recognition in investor relations. Currently serving as Vice President of Discovery Sciences at Monte Rosa Therapeutics, he continues to make significant contributions to the life sciences industry.
Kevin Lumb
Work Experience
Vice President, Discovery Sciences at
Monte Rosa Therapeutics
January 2023 - Present
Vice President, Biology at
Avilar Therapeutics, Inc.
January 2021 - January 2023
Global Head, Lead Discovery & Profiling, Discovery Sciences at
The Janssen Pharmaceutical Companies of Johnson & Johnson
January 2016 - January 2020
Scientific Director, Emerging Science & Innovation, Discovery Sciences at
The Janssen Pharmaceutical Companies of Johnson & Johnson
January 2014 - January 2016
Department Head, Protein Science at
Merck
January 2012 - January 2014
Department Head, Biochemical Screening/Global Structural Biology at
Merck
January 2009 - January 2012
Department Head, Global Structural Biology at
Merck
January 2007 - January 2009
Principal Scientist, Research Technologies at
Bayer AG
January 2004 - January 2007
Senior Scientist, Research Technologies at
Bayer Pharmaceuticals
January 2002 - January 2004
Kevin Lumb
Education
University of Oxford, Doctor Of Philosophy (D.Phil.)
Whitehead Institute at MIT, Postdoctoral Research
University College London, Bachelor Of Science With Honours (B.Sc.)
Frequently Asked Questions about Kevin Lumb
What is Kevin Lumb email address?
Kevin Lumb's primary email address is *****@monterosatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kevin Lumb work for?
Kevin Lumb is a Vice President, Discovery Sciences at Monte Rosa Therapeutics, a company specializing in Commercial physical research.
Where Kevin Lumb graduated from?
Kevin Lumb holds a degree in Biophysics And Structural Biology (Advisor: Sir Christopher M. Dobson Frs) from University of Oxford.
How can I directly contact Kevin Lumb?
To contact Kevin Lumb directly, you can use the email address *****@monterosatx.com. Complete contact information is available upon registration with Muraena.
Who is Kevin Lumb?
Kevin Lumb is a seasoned leader in drug discovery, specializing in pharmacology and structural biology. With a proven track record of building high-performing teams, he has effectively managed both internal and external resources to drive innovative drug development. His expertise spans from target validation to preclinical candidate discovery, showcasing his ability to navigate complex processes and clarify executable strategies. Kevin has authored 54 publications and holds 9 patents, reflecting his deep commitment to advancing scientific knowledge. His leadership style emphasizes talent development and creating self-managing teams, fostering an environment of collaboration and innovation. He has successfully led teams in various prestigious organizations, including Merck and Janssen, demonstrating his adaptability across different corporate cultures. Kevin's strategic vision in capital planning and execution has also garnered him recognition in investor relations. Currently serving as Vice President of Discovery Sciences at Monte Rosa Therapeutics, he continues to make significant contributions to the life sciences industry.
Kevin`s contact details
*****@monterosatx.com
**********@avilar-tx.com
Colleagues
Chief Medical Officer
VP - Corporate Controller, Principal Accounting Officer
Vice President of Quality
Vice President, Chemistry at Monte Rosa Therapeutics
Vice-President, Head of Proteomics
VP Oncology
VP of Nonclinical Development & Clinical Pharmacology
Chief Information Officer
Chief Operating Officer
Vice President